Meet Your 2021 BioBuzz Award Winners

Orange banner with photos of people, with text saying "2nd Annual BioBuzz Awards - Presenting Your Winners"
Published on :

Today, we are excited to announce the winners of our 2nd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.

2021 BioBuzz Awards Finalists

Published on :

We’re excited to announce this year’s finalists for the second annual 2021 BioBuzz Awards. These awards celebrate the people and companies across our regional community and their efforts and accomplishments to impact human health and build a stronger biotech community.

Biotech Careers: Everyone Can Take Part in Shaping the Future

Maryland has built “one of the nation’s strongest life sciences industries”.
Published on :

The growing life sciences ecosystem in Maryland has become a shining star in the BioHealth Capital Region. The region has seen explosive growth driven by billions of federal dollars aimed at R&D efforts to combat the COVID-19 threat. And that continued growth has become a magnet for a robust supply of life sciences talent that will continue to shape the future of the state and region.

Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

Seven Public Cell Therapy Companies Delivering Opportunities for Investors and Patients

Published on :

Cell therapies have grown to become a prevailing field dominating new medical breakthroughs with the promise of treatments and cures for multiple diseases. The biopharma hubs of Philadelphia and Maryland have emerged as important drivers of this new wave of medicine, build on the foundation of renowned research institutes, universities, and a number of successful cell therapy companies who have paved the way forward in this field.

Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

CaroElise Ataku: Driven by a Shared Purpose in Producing Personalized Cell Therapies to Fight Cancer

Published on :

Kite specializes in personalized chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain blood cancers and CTSs play a critical role in the process that develops those therapies. Each day, a CTS receives batches of patient cells in their own hands, with each batch representing a new patient. Most of these patients have already exhausted other treatment options. The patient focus and the company’s mission to get these therapies to the people who need them most is the foundation of employees’ day-to-day work.